» Articles » PMID: 32679085

Serology-informed Estimates of SARS-CoV-2 Infection Fatality Risk in Geneva, Switzerland

Overview
Date 2020 Jul 18
PMID 32679085
Citations 95
Authors
Affiliations
Soon will be listed here.
Citing Articles

Improving case fatality ratio estimates in ongoing pandemics through case-to-death time distribution analysis.

Farooq Z, Sjodin H, Rocklov J, Brannstrom A Sci Rep. 2025; 15(1):5402.

PMID: 39948196 PMC: 11825655. DOI: 10.1038/s41598-025-89441-y.


The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England.

Ward T, Fyles M, Glaser A, Paton R, Ferguson W, Overton C Nat Commun. 2024; 15(1):4633.

PMID: 38821930 PMC: 11143367. DOI: 10.1038/s41467-024-47199-3.


Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models.

Bouman J, Hauser A, Grimm S, Wohlfender M, Bhatt S, Semenova E PLoS Comput Biol. 2024; 20(4):e1011575.

PMID: 38683878 PMC: 11081492. DOI: 10.1371/journal.pcbi.1011575.


Estimates of early outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data.

Vaughan T, Scire J, Nadeau S, Stadler T Proc Natl Acad Sci U S A. 2024; 121(2):e2308125121.

PMID: 38175864 PMC: 10786264. DOI: 10.1073/pnas.2308125121.


Psychological impact of COVID-19 and determinants among Spanish university students.

Cebrino J, Portero de la Cruz S Front Public Health. 2023; 11:1252849.

PMID: 37920580 PMC: 10619672. DOI: 10.3389/fpubh.2023.1252849.


References
1.
Stringhini S, Wisniak A, Piumatti G, Azman A, Lauer S, Baysson H . Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020; 396(10247):313-319. PMC: 7289564. DOI: 10.1016/S0140-6736(20)31304-0. View

2.
Russell T, Hellewell J, Jarvis C, van Zandvoort K, Abbott S, Ratnayake R . Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Euro Surveill. 2020; 25(12). PMC: 7118348. DOI: 10.2807/1560-7917.ES.2020.25.12.2000256. View

3.
Takahashi S, Greenhouse B, Rodriguez-Barraquer I . Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?. J Infect Dis. 2020; 222(11):1772-1775. PMC: 7499591. DOI: 10.1093/infdis/jiaa523. View

4.
Nishiura H, Klinkenberg D, Roberts M, Heesterbeek J . Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic. PLoS One. 2009; 4(8):e6852. PMC: 2729920. DOI: 10.1371/journal.pone.0006852. View

5.
Meyerowitz-Katz G, Merone L . A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis. 2020; 101:138-148. PMC: 7524446. DOI: 10.1016/j.ijid.2020.09.1464. View